Author

Poorva Juneja

Frederick National Laboratory for Cancer ResearchORCID 0009-0009-0267-9057Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Beverly A. TeicheriD· 1 shared James H. DoroshowiD· 1 shared Joel MorrisiD· 1 shared Melinda G. HollingsheadiD· 1 shared Naoko TakebeiD· 1 shared Nathan P. CoussensiD· 1 shared Raymond G. FoxiD· 1 shared Samantha B. KempiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Beverly A. TeicherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedSep 17, 2025

Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types

Zahra Davoudi, Thomas Steven Dexheimer, Nathan P. Coussens…·Beverly A. Teicher

This study screens combinations of RAS pathway inhibitors with targeted agents in patient-derived spheroids with KRAS variants, identifying effective combinations that reduce viability.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky